NO20040965L - Blandinger og fremgangsmater for priming av monocyttiske dendrittiske celler og T-celler i TH-1-respons. - Google Patents

Blandinger og fremgangsmater for priming av monocyttiske dendrittiske celler og T-celler i TH-1-respons.

Info

Publication number: NO20040965L
Authority: NO; Norway
Prior art keywords: cells; mixtures; response; methods; monocytic dendritic
Prior art date: 2001-09-06

Application number

NO20040965A

Other languages

English (en)

Other versions

NO338147B1 (no

Inventor

Marnix L Bosch

Original Assignee

Northwest Biotherapeutics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-06

Filing date

2004-03-05

Publication date

2004-04-23

2004-03-05 Application filed by Northwest Biotherapeutics Inc filed Critical Northwest Biotherapeutics Inc

2004-04-23 Publication of NO20040965L publication Critical patent/NO20040965L/no

2016-08-01 Publication of NO338147B1 publication Critical patent/NO338147B1/no

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5428—IL-10
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5434—IL-12
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/72—Undefined extracts from bacteria
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/24—Interferons [IFN]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Wood Science & Technology (AREA)
Medicinal Chemistry (AREA)
Hematology (AREA)
Cell Biology (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
General Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Public Health (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Developmental Biology & Embryology (AREA)
Virology (AREA)
Urology & Nephrology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Analytical Chemistry (AREA)
Physics & Mathematics (AREA)
Food Science & Technology (AREA)

NO20040965A 2001-09-06 2004-03-05 Fremgangsmåte for fremstilling av en moden dendrittcelle-populasjon og in vitro fremgangsmåte for produsering av T-celler. NO338147B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US31759201P	2001-09-06	2001-09-06
PCT/US2002/028620 WO2003022215A2 (en)	2001-09-06	2002-09-06	Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response

Publications (2)

Publication Number	Publication Date
NO20040965L true NO20040965L (no)	2004-04-23
NO338147B1 NO338147B1 (no)	2016-08-01

Family

ID=32654226

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO20040965A NO338147B1 (no)	2001-09-06	2004-03-05	Fremgangsmåte for fremstilling av en moden dendrittcelle-populasjon og in vitro fremgangsmåte for produsering av T-celler.
NO20151562A NO20151562A1 (no)	2001-09-06	2015-11-16	Blandinger og fremgangsmåter for priming av monocytt-dendrittceller og T-celler i Th-1-respons.

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO20151562A NO20151562A1 (no)	2001-09-06	2015-11-16	Blandinger og fremgangsmåter for priming av monocytt-dendrittceller og T-celler i Th-1-respons.

Country Status (18)

Country	Link
US (2)	US20050059151A1 (no)
EP (3)	EP2322603B1 (no)
JP (3)	JP2005505270A (no)
KR (3)	KR20050027163A (no)
CN (2)	CN1636229B (no)
AU (1)	AU2008221592B2 (no)
BR (1)	BRPI0212545B8 (no)
CA (1)	CA2459713C (no)
DK (2)	DK2322603T3 (no)
ES (2)	ES2598109T3 (no)
HK (1)	HK1079989A1 (no)
IL (3)	IL160720A0 (no)
MX (1)	MXPA04002147A (no)
NO (2)	NO338147B1 (no)
NZ (1)	NZ531530A (no)
PL (1)	PL372098A1 (no)
PT (2)	PT1441591T (no)
WO (1)	WO2003022215A2 (no)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT412145B (de) *	2002-09-13	2004-10-25	Forsch Krebskranke Kinder	Verfahren zur herstellung eines zellulären immuntherapeutikums auf basis von il-12-freisetzenden dendritischen zellen
US20040057935A1 (en) *	2002-09-20	2004-03-25	Cedars-Sinai Medical Center	Intratumoral delivery of dendritic cells
RU2348418C2 (ru) *	2002-12-06	2009-03-10	Норсуэст Байотерапьютикс, Инк.	Введение дендритных клеток, подвергнутых частичному созреванию in vitro, для лечения опухолей
AU2004214896A1 (en) *	2003-02-27	2004-09-10	Northwest Biotherapeutics, Inc.	Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines
EP1484064A1 (en)	2003-06-04	2004-12-08	Gesellschaft für Biotechnologische Forschung	Therapeutical composition containing dentritic cells and use thereof
WO2005037995A2 (en) *	2003-10-06	2005-04-28	Cedars-Sinai Medical Center	Use of cox-2 inhibitor to prevent t-cell anergy induced by dendritic cell therapy
EP1676132B1 (en) *	2003-10-21	2014-01-22	Cedars-Sinai Medical Center	Combination of chemotherapy and administration of glioma-antigen-pulsed dendritic cells in the treatment of glioma
WO2005042737A1 (ja) *	2003-11-04	2005-05-12	Dnavec Research Inc.	遺伝子導入された樹状細胞の製造方法
JPWO2006001120A1 (ja)	2004-06-24	2008-04-17	株式会社ディナベック研究所	マイナス鎖ｒｎａウイルスを含む抗癌剤
CA2632263C (en) *	2005-12-08	2022-01-11	Northwest Biotherapeutics, Inc.	Compositions and methods for inducing the activation of immature monocytic dendritic cells
EP1840206A1 (en) *	2006-03-28	2007-10-03	Gsf-Forschungszentrum Für Umwelt Und Gesundheit, Gmbh	Compositions for the preparation of mature dendritic cells
US8129184B2 (en) *	2006-09-26	2012-03-06	Cedars-Sinai Medical Center	Cancer stem cell antigen vaccines and methods
US8097256B2 (en)	2006-09-28	2012-01-17	Cedars-Sinai Medical Center	Cancer vaccines and vaccination methods
DK2328923T3 (en) *	2008-09-02	2016-03-21	Cedars Sinai Medical Center	CD133 epitopes
WO2010129895A2 (en)	2009-05-07	2010-11-11	Immunocellular Therapeutics, Ltd.	Cd133 epitopes
NZ628292A (en) *	2012-02-02	2016-09-30	Neostem Oncology Llc	Pluripotent germ layer origin antigen presenting cancer vaccine
WO2013180481A1 (ko)	2012-05-31	2013-12-05	제이더블유크레아젠 주식회사	수지상세포 성숙화 조성물 및 이를 이용하여 항원 특이적 수지상세포를 제조하는 방법
AU2020203845C1 (en) *	2012-09-06	2022-08-11	Orbis Health Solutions, Llc	Tumor lysate loaded particles
US9744193B2 (en)	2012-09-06	2017-08-29	Orbis Health Solutions Llc	Tumor lysate loaded particles
WO2014093454A1 (en)	2012-12-12	2014-06-19	Orbis Health Solutions, Llc	Compositions and methods for tissue regeneration
US20140234351A1 (en)	2013-02-14	2014-08-21	Immunocellular Therapeutics, Ltd.	Cancer vaccines and vaccination methods
CN112891522A (zh) *	2013-09-05	2021-06-04	奥比思健康解决方案有限责任公司	装载了肿瘤裂解物的微粒
CN106456532B (zh)	2014-03-05	2020-07-24	奥比思健康解决方案有限责任公司	使用酵母细胞壁颗粒的疫苗递送系统
US10089693B1 (en) *	2014-05-20	2018-10-02	State Farm Mutual Automobile Insurance Company	Fully autonomous vehicle insurance pricing
US9972054B1 (en)	2014-05-20	2018-05-15	State Farm Mutual Automobile Insurance Company	Accident fault determination for autonomous vehicles
US11669090B2 (en)	2014-05-20	2023-06-06	State Farm Mutual Automobile Insurance Company	Autonomous vehicle operation feature monitoring and evaluation of effectiveness
US10373259B1 (en)	2014-05-20	2019-08-06	State Farm Mutual Automobile Insurance Company	Fully autonomous vehicle insurance pricing
US10599155B1 (en)	2014-05-20	2020-03-24	State Farm Mutual Automobile Insurance Company	Autonomous vehicle operation feature monitoring and evaluation of effectiveness
US9783159B1 (en)	2014-07-21	2017-10-10	State Farm Mutual Automobile Insurance Company	Methods of theft prevention or mitigation
US10246097B1 (en)	2014-11-13	2019-04-02	State Farm Mutual Automobile Insurance Company	Autonomous vehicle operator identification
EP3317402B1 (en)	2015-06-30	2024-02-14	Universidade Nova de Lisboa	A viable cell population, method for production and uses thereof
US11124768B2 (en) *	2015-06-30	2021-09-21	Northwest Biotherapeutics, Inc.	Optimally activated dendritic cells that induce an improved or increased anti-tumor immune response
US20210166323A1 (en)	2015-08-28	2021-06-03	State Farm Mutual Automobile Insurance Company	Determination of driver or vehicle discounts and risk profiles based upon vehicular travel environment
US11242051B1 (en)	2016-01-22	2022-02-08	State Farm Mutual Automobile Insurance Company	Autonomous vehicle action communications
US10324463B1 (en)	2016-01-22	2019-06-18	State Farm Mutual Automobile Insurance Company	Autonomous vehicle operation adjustment based upon route
US20210295439A1 (en)	2016-01-22	2021-09-23	State Farm Mutual Automobile Insurance Company	Component malfunction impact assessment
US10395332B1 (en)	2016-01-22	2019-08-27	State Farm Mutual Automobile Insurance Company	Coordinated autonomous vehicle automatic area scanning
US11441916B1 (en)	2016-01-22	2022-09-13	State Farm Mutual Automobile Insurance Company	Autonomous vehicle trip routing
US11719545B2 (en)	2016-01-22	2023-08-08	Hyundai Motor Company	Autonomous vehicle component damage and salvage assessment
US10134278B1 (en)	2016-01-22	2018-11-20	State Farm Mutual Automobile Insurance Company	Autonomous vehicle application
KR102038114B1 (ko) *	2016-02-26	2019-10-30	주식회사 엘지화학	광학 점착제용 (메타)아크릴레이트기 함유 벤조페논의 제조방법 및 광학 점착제 조성물
WO2018160666A1 (en) *	2017-02-28	2018-09-07	University Of Pittsburgh-Of The Commonwealth System Of Higher Education	Short-term activated dc1s and methods for their production and use
WO2019183924A1 (en) *	2018-03-30	2019-10-03	Syz Cell Therapy Co.	Improved multiple antigen specific cell therapy methods
EP4041298A4 (en) *	2019-10-07	2024-07-24	Northwest Biotherapeutics Inc	IN VITRO METHODS AND COMPOSITIONS FOR ENHANCING ACTIVATION OF DENDRITIC CELLS AND T CELLS AND FOR INDUCING A TH -1 IMMUNE RESPONSE

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5162504A (en)	1988-06-03	1992-11-10	Cytogen Corporation	Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients
US5366866A (en) *	1991-07-25	1994-11-22	Duke University	Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies OXA and OXB
US5227471A (en) *	1992-01-30	1993-07-13	Eastern Virginia Medical School Of The Medical College Of Hampton Roads	Monoclonal antibody PD41 that binds to a prostate mucin antigen that is expressed in human prostatic carcinoma
US5788963A (en)	1995-07-31	1998-08-04	Pacific Northwest Cancer Foundation	Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
ES2323818T3 (es) *	1995-10-04	2009-07-24	Immunex Corporation	Factor estimulador de las celulas dendriticas.
US7659119B2 (en) *	1996-02-12	2010-02-09	Argos Therapeutics, Inc.	Method and compositions for obtaining mature dendritic cells
US6274378B1 (en) *	1997-10-27	2001-08-14	The Rockefeller University	Methods and compositions for obtaining mature dendritic cells
JP2000143534A (ja) *	1998-11-13	2000-05-23	Asahi Chem Ind Co Ltd	樹状細胞ワクチン及びその製造方法
JP2000279181A (ja) *	1999-04-01	2000-10-10	Japan Science & Technology Corp	ヒト樹状細胞の発現遺伝子群
WO2001048154A1 (fr) *	1999-12-28	2001-07-05	Toyoshima, Kumao	Agent de maturation pour cellules dendritiques immatures
US6247378B1 (en) *	2000-01-06	2001-06-19	Deere & Company	Operator control device for an infinitely variable transmission
JP4841794B2 (ja) *	2000-05-12	2011-12-21	ノースウエストバイオセラピューティクス，インコーポレイティド	ヒト樹状細胞による外因性抗原のクラスｉ提示を増加させる方法
EP1352052B1 (en) *	2001-01-15	2006-02-08	I.D.M. Immuno-Designed Molecules	Method for preparing submicron particle suspensions of pharmaceutical agents
WO2003010292A2 (en) *	2001-07-25	2003-02-06	Northwest Biotherapeutics, Inc.	Methods and apparatus for enrichment and culture of monocytic dendritic cell precursors

2002
- 2002-09-06 ES ES02761594.7T patent/ES2598109T3/es not_active Expired - Lifetime
- 2002-09-06 CN CN028198174A patent/CN1636229B/zh not_active Expired - Fee Related
- 2002-09-06 MX MXPA04002147A patent/MXPA04002147A/es active IP Right Grant
- 2002-09-06 KR KR1020047003386A patent/KR20050027163A/ko not_active Application Discontinuation
- 2002-09-06 EP EP10181985.2A patent/EP2322603B1/en not_active Expired - Lifetime
- 2002-09-06 CN CN201210470111.XA patent/CN102973928B/zh not_active Expired - Fee Related
- 2002-09-06 IL IL16072002A patent/IL160720A0/xx unknown
- 2002-09-06 PT PT2761594T patent/PT1441591T/pt unknown
- 2002-09-06 PT PT101819852T patent/PT2322603T/pt unknown
- 2002-09-06 EP EP02761594.7A patent/EP1441591B1/en not_active Expired - Lifetime
- 2002-09-06 DK DK10181985.2T patent/DK2322603T3/da active
- 2002-09-06 PL PL02372098A patent/PL372098A1/xx not_active Application Discontinuation
- 2002-09-06 ES ES10181985T patent/ES2766299T3/es not_active Expired - Lifetime
- 2002-09-06 DK DK02761594.7T patent/DK1441591T3/en active
- 2002-09-06 EP EP19202820.7A patent/EP3653055A1/en not_active Withdrawn
- 2002-09-06 JP JP2003526345A patent/JP2005505270A/ja active Pending
- 2002-09-06 KR KR1020147023675A patent/KR101803702B1/ko active IP Right Grant
- 2002-09-06 BR BRPI0212545A patent/BRPI0212545B8/pt not_active IP Right Cessation
- 2002-09-06 KR KR1020117012621A patent/KR20110081341A/ko not_active Application Discontinuation
- 2002-09-06 NZ NZ531530A patent/NZ531530A/en not_active IP Right Cessation
- 2002-09-06 WO PCT/US2002/028620 patent/WO2003022215A2/en active Application Filing
- 2002-09-06 US US10/488,744 patent/US20050059151A1/en not_active Abandoned
- 2002-09-06 CA CA2459713A patent/CA2459713C/en not_active Expired - Lifetime
2004
- 2004-03-03 IL IL160720A patent/IL160720A/en active IP Right Grant
- 2004-03-05 NO NO20040965A patent/NO338147B1/no not_active IP Right Cessation
2006
- 2006-01-04 HK HK06100064.5A patent/HK1079989A1/xx not_active IP Right Cessation
2008
- 2008-05-29 US US12/129,549 patent/US20080254064A1/en not_active Abandoned
- 2008-09-19 AU AU2008221592A patent/AU2008221592B2/en not_active Ceased
2011
- 2011-07-04 JP JP2011148711A patent/JP5777956B2/ja not_active Expired - Fee Related
2012
- 2012-04-18 IL IL219266A patent/IL219266A/en active IP Right Grant
2015
- 2015-03-02 JP JP2015040165A patent/JP6114768B2/ja not_active Expired - Fee Related
- 2015-11-16 NO NO20151562A patent/NO20151562A1/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
DK1441591T3 (en)	2017-05-22
BRPI0212545B1 (pt)	2019-12-03
IL160720A0 (en)	2004-08-31
JP6114768B2 (ja)	2017-04-12
BRPI0212545A8 (pt)	2019-10-15
WO2003022215A2 (en)	2003-03-20
PT2322603T (pt)	2020-01-21
HK1079989A1 (en)	2006-04-21
EP1441591A2 (en)	2004-08-04
DK2322603T3 (da)	2020-01-27
EP1441591A4 (en)	2006-06-07
KR20050027163A (ko)	2005-03-17
KR20140116544A (ko)	2014-10-02
EP3653055A1 (en)	2020-05-20
WO2003022215A3 (en)	2003-11-13
KR20110081341A (ko)	2011-07-13
ES2766299T3 (es)	2020-06-12
EP1441591B1 (en)	2016-06-29
EP2322603A1 (en)	2011-05-18
US20080254064A1 (en)	2008-10-16
CN102973928A (zh)	2013-03-20
MXPA04002147A (es)	2005-03-07
JP2005505270A (ja)	2005-02-24
ES2598109T3 (es)	2017-01-25
NZ531530A (en)	2007-01-26
JP2015107133A (ja)	2015-06-11
PL372098A1 (en)	2005-07-11
IL219266A0 (en)	2012-06-28
AU2008221592B2 (en)	2012-12-20
JP5777956B2 (ja)	2015-09-16
JP2011188872A (ja)	2011-09-29
PT1441591T (pt)	2016-10-06
KR101803702B1 (ko)	2017-12-01
US20050059151A1 (en)	2005-03-17
NO20151562A1 (no)	2015-11-16
IL219266A (en)	2014-02-27
CA2459713C (en)	2015-08-18
NO338147B1 (no)	2016-08-01
BR0212545A (pt)	2005-01-18
IL160720A (en)	2012-05-31
EP2322603B1 (en)	2019-10-16
CN1636229B (zh)	2012-12-19
CN1636229A (zh)	2005-07-06
CA2459713A1 (en)	2003-03-20
BRPI0212545B8 (pt)	2021-05-25
AU2008221592A1 (en)	2008-10-16
CN102973928B (zh)	2019-03-15

Publication	Publication Date	Title
NO20040965L (no)	2004-04-23	Blandinger og fremgangsmater for priming av monocyttiske dendrittiske celler og T-celler i TH-1-respons.
DK1461134T3 (da)	2007-07-30	Flertrinsseparationsenhed og fremgangsmåde
DK1380085T3 (da)	2012-08-27	Justerbart, skalerbart reolstrømforsyningssystem og fremgangsmåde
ITPD20020138A1 (it)	2003-11-24	Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima.
DE50208968D1 (de)	2007-01-25	Stromrichtereinheit in modulbauweise
AU2003253897A8 (en)	2004-02-02	Dendritic cell pontentiation
IL151415A0 (en)	2003-04-10	Electrical cells, components and methods
GB2394121B (en)	2005-12-07	Circuit board support arrangement,method,and method for using the same
NO20052363L (no)	2005-08-08	Interferon-alfa polypeptider og konjugater
ITMI20022347A1 (it)	2004-05-07	Metodo di comunicazione con tempo di risposta ridotto in
AU2003247449A1 (en)	2003-12-19	Nano-ceramics and method thereof
NO20040649L (no)	2004-08-16	Forbindelsesanordning, brenselcelle og brenselcellestakk.
AU2002319895A1 (en)	2003-12-19	Improved in scaffold connections
DK1573016T3 (da)	2014-07-28	Genreporterassay, -kit og -celler.
DE50305974D1 (de)	2007-01-25	Rollstuhl, insbesondere Elektrorollstuhl
GB0612368D0 (en)	2006-08-30	I.V Support Stand And Components Therefor
AU2003280643A1 (en)	2004-05-25	Membrane protein originating in mast cells
DE10045123B8 (de)	2008-01-24	Das C. albicans TEC1 GEN(CaTEC1) und das kodierte Tec1p Protein
TW525806U (en)	2003-03-21	Cash receiving platform structure
BR8200234Y1 (pt)	2011-08-09	disposição construtiva em cámara escura individual e portátil (ceip).
BR8201890Y1 (pt)	2011-08-23	disposição introduzida em bombona.
SE0103024L (sv)	2003-03-14	Nyheter inom stamcellsområdet
BR8102837Y1 (pt)	2009-08-11	disposição construtiva introduzida em calçado.
BR7901568Y1 (pt)	2009-01-13	disposiÇço construtiva introduzida em badisco.
BR8001596Y1 (pt)	2009-05-05	disposição introduzida em turbo compressor.

Legal Events

Date	Code	Title	Description
2022-04-25	MM1K	Lapsed by not paying the annual fees